img

Global Monkeypox Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Monkeypox Treatment Market Insights, Forecast to 2034

Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
Market Analysis and InsightsGlobal Monkeypox Treatment Market
Global Monkeypox Treatment market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Monkeypox Treatment industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Monkeypox Treatment key companies include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd. and Mylan N.V., etc. Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Monkeypox Treatment were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Monkeypox Treatment market and estimated to attract more attentions from industry insiders and investors.
Monkeypox Treatment can be divided into Oral and Injectable, etc. Oral is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Monkeypox Treatment is widely used in various fields, such as Hospital Pharmacy, Online Pharmacy and Retail Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Monkeypox Treatment industry development. In 2022, global % revenue of Monkeypox Treatment went into Hospital Pharmacy filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Monkeypox Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Monkeypox Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Segment by Type
Oral
Injectable

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Monkeypox Treatment introduction, etc. Monkeypox Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Monkeypox Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Monkeypox Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Treatment Market Perspective (2018-2033)
2.2 Global Monkeypox Treatment Growth Trends by Region
2.2.1 Monkeypox Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Monkeypox Treatment Historic Market Size by Region (2018-2023)
2.2.3 Monkeypox Treatment Forecasted Market Size by Region (2024-2033)
2.3 Monkeypox Treatment Market Dynamics
2.3.1 Monkeypox Treatment Industry Trends
2.3.2 Monkeypox Treatment Market Drivers
2.3.3 Monkeypox Treatment Market Challenges
2.3.4 Monkeypox Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Monkeypox Treatment by Players
3.1.1 Global Monkeypox Treatment Revenue by Players (2018-2023)
3.1.2 Global Monkeypox Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Monkeypox Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Monkeypox Treatment Market Concentration Ratio
3.4.1 Global Monkeypox Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Treatment Revenue in 2022
3.5 Global Key Players of Monkeypox Treatment Head office and Area Served
3.6 Global Key Players of Monkeypox Treatment, Product and Application
3.7 Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Treatment Breakdown Data by Type
4.1 Global Monkeypox Treatment Historic Market Size by Type (2018-2023)
4.2 Global Monkeypox Treatment Forecasted Market Size by Type (2024-2033)
5 Monkeypox Treatment Breakdown Data by Application
5.1 Global Monkeypox Treatment Historic Market Size by Application (2018-2023)
5.2 Global Monkeypox Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Monkeypox Treatment Market Size (2018-2033)
6.2 North America Monkeypox Treatment Market Size by Type
6.2.1 North America Monkeypox Treatment Market Size by Type (2018-2023)
6.2.2 North America Monkeypox Treatment Market Size by Type (2024-2033)
6.2.3 North America Monkeypox Treatment Market Share by Type (2018-2033)
6.3 North America Monkeypox Treatment Market Size by Application
6.3.1 North America Monkeypox Treatment Market Size by Application (2018-2023)
6.3.2 North America Monkeypox Treatment Market Size by Application (2024-2033)
6.3.3 North America Monkeypox Treatment Market Share by Application (2018-2033)
6.4 North America Monkeypox Treatment Market Size by Country
6.4.1 North America Monkeypox Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Monkeypox Treatment Market Size by Country (2018-2023)
6.4.3 North America Monkeypox Treatment Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Monkeypox Treatment Market Size (2018-2033)
7.2 Europe Monkeypox Treatment Market Size by Type
7.2.1 Europe Monkeypox Treatment Market Size by Type (2018-2023)
7.2.2 Europe Monkeypox Treatment Market Size by Type (2024-2033)
7.2.3 Europe Monkeypox Treatment Market Share by Type (2018-2033)
7.3 Europe Monkeypox Treatment Market Size by Application
7.3.1 Europe Monkeypox Treatment Market Size by Application (2018-2023)
7.3.2 Europe Monkeypox Treatment Market Size by Application (2024-2033)
7.3.3 Europe Monkeypox Treatment Market Share by Application (2018-2033)
7.4 Europe Monkeypox Treatment Market Size by Country
7.4.1 Europe Monkeypox Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Monkeypox Treatment Market Size by Country (2018-2023)
7.4.3 Europe Monkeypox Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Monkeypox Treatment Market Size (2018-2033)
8.2 China Monkeypox Treatment Market Size by Type
8.2.1 China Monkeypox Treatment Market Size by Type (2018-2023)
8.2.2 China Monkeypox Treatment Market Size by Type (2024-2033)
8.2.3 China Monkeypox Treatment Market Share by Type (2018-2033)
8.3 China Monkeypox Treatment Market Size by Application
8.3.1 China Monkeypox Treatment Market Size by Application (2018-2023)
8.3.2 China Monkeypox Treatment Market Size by Application (2024-2033)
8.3.3 China Monkeypox Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Monkeypox Treatment Market Size (2018-2033)
9.2 Asia Monkeypox Treatment Market Size by Type
9.2.1 Asia Monkeypox Treatment Market Size by Type (2018-2023)
9.2.2 Asia Monkeypox Treatment Market Size by Type (2024-2033)
9.2.3 Asia Monkeypox Treatment Market Share by Type (2018-2033)
9.3 Asia Monkeypox Treatment Market Size by Application
9.3.1 Asia Monkeypox Treatment Market Size by Application (2018-2023)
9.3.2 Asia Monkeypox Treatment Market Size by Application (2024-2033)
9.3.3 Asia Monkeypox Treatment Market Share by Application (2018-2033)
9.4 Asia Monkeypox Treatment Market Size by Region
9.4.1 Asia Monkeypox Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Monkeypox Treatment Market Size by Region (2018-2023)
9.4.3 Asia Monkeypox Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Monkeypox Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Monkeypox Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Monkeypox Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Details
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Monkeypox Treatment Introduction
11.1.4 Bavarian Nordic Revenue in Monkeypox Treatment Business (2018-2023)
11.1.5 Bavarian Nordic Recent Developments
11.2 Chimerix, Inc.
11.2.1 Chimerix, Inc. Company Details
11.2.2 Chimerix, Inc. Business Overview
11.2.3 Chimerix, Inc. Monkeypox Treatment Introduction
11.2.4 Chimerix, Inc. Revenue in Monkeypox Treatment Business (2018-2023)
11.2.5 Chimerix, Inc. Recent Developments
11.3 CIDIC Company Limited
11.3.1 CIDIC Company Limited Company Details
11.3.2 CIDIC Company Limited Business Overview
11.3.3 CIDIC Company Limited Monkeypox Treatment Introduction
11.3.4 CIDIC Company Limited Revenue in Monkeypox Treatment Business (2018-2023)
11.3.5 CIDIC Company Limited Recent Developments
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Details
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Monkeypox Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2018-2023)
11.4.5 Emcure Pharmaceuticals Recent Developments
11.5 Emergent
11.5.1 Emergent Company Details
11.5.2 Emergent Business Overview
11.5.3 Emergent Monkeypox Treatment Introduction
11.5.4 Emergent Revenue in Monkeypox Treatment Business (2018-2023)
11.5.5 Emergent Recent Developments
11.6 Gilead Sciences Inc.
11.6.1 Gilead Sciences Inc. Company Details
11.6.2 Gilead Sciences Inc. Business Overview
11.6.3 Gilead Sciences Inc. Monkeypox Treatment Introduction
11.6.4 Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2018-2023)
11.6.5 Gilead Sciences Inc. Recent Developments
11.7 Hetero Drugs Limited
11.7.1 Hetero Drugs Limited Company Details
11.7.2 Hetero Drugs Limited Business Overview
11.7.3 Hetero Drugs Limited Monkeypox Treatment Introduction
11.7.4 Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2018-2023)
11.7.5 Hetero Drugs Limited Recent Developments
11.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
11.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
11.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
11.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Introduction
11.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2018-2023)
11.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Developments
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Monkeypox Treatment Introduction
11.9.4 Mylan N.V. Revenue in Monkeypox Treatment Business (2018-2023)
11.9.5 Mylan N.V. Recent Developments
11.10 Olon S.p.A.
11.10.1 Olon S.p.A. Company Details
11.10.2 Olon S.p.A. Business Overview
11.10.3 Olon S.p.A. Monkeypox Treatment Introduction
11.10.4 Olon S.p.A. Revenue in Monkeypox Treatment Business (2018-2023)
11.10.5 Olon S.p.A. Recent Developments
11.11 Piramal Pharma Solutions
11.11.1 Piramal Pharma Solutions Company Details
11.11.2 Piramal Pharma Solutions Business Overview
11.11.3 Piramal Pharma Solutions Monkeypox Treatment Introduction
11.11.4 Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2018-2023)
11.11.5 Piramal Pharma Solutions Recent Developments
11.12 SIGA Technologies Inc.
11.12.1 SIGA Technologies Inc. Company Details
11.12.2 SIGA Technologies Inc. Business Overview
11.12.3 SIGA Technologies Inc. Monkeypox Treatment Introduction
11.12.4 SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2018-2023)
11.12.5 SIGA Technologies Inc. Recent Developments
11.13 Sonofi SA
11.13.1 Sonofi SA Company Details
11.13.2 Sonofi SA Business Overview
11.13.3 Sonofi SA Monkeypox Treatment Introduction
11.13.4 Sonofi SA Revenue in Monkeypox Treatment Business (2018-2023)
11.13.5 Sonofi SA Recent Developments
11.14 Teva Pharmaceutical Industries Limited
11.14.1 Teva Pharmaceutical Industries Limited Company Details
11.14.2 Teva Pharmaceutical Industries Limited Business Overview
11.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2018-2023)
11.14.5 Teva Pharmaceutical Industries Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Monkeypox Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Global Monkeypox Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Monkeypox Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Monkeypox Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Monkeypox Treatment Market Share by Region (2018-2023)
Table 8. Global Monkeypox Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Monkeypox Treatment Market Share by Region (2024-2033)
Table 10. Monkeypox Treatment Market Trends
Table 11. Monkeypox Treatment Market Drivers
Table 12. Monkeypox Treatment Market Challenges
Table 13. Monkeypox Treatment Market Restraints
Table 14. Global Monkeypox Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Monkeypox Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top Monkeypox Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2022)
Table 17. Global Monkeypox Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Monkeypox Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Monkeypox Treatment, Headquarters and Area Served
Table 20. Global Key Players of Monkeypox Treatment, Product and Application
Table 21. Global Key Players of Monkeypox Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Monkeypox Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Monkeypox Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Monkeypox Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Monkeypox Treatment Revenue Share by Application (2018-2023)
Table 29. Global Monkeypox Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Monkeypox Treatment Revenue Share by Application (2024-2033)
Table 31. North America Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Monkeypox Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Monkeypox Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Monkeypox Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Monkeypox Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Monkeypox Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Monkeypox Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Monkeypox Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 63. Bavarian Nordic Company Details
Table 64. Bavarian Nordic Business Overview
Table 65. Bavarian Nordic Monkeypox Treatment Product
Table 66. Bavarian Nordic Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 67. Bavarian Nordic Recent Developments
Table 68. Chimerix, Inc. Company Details
Table 69. Chimerix, Inc. Business Overview
Table 70. Chimerix, Inc. Monkeypox Treatment Product
Table 71. Chimerix, Inc. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 72. Chimerix, Inc. Recent Developments
Table 73. CIDIC Company Limited Company Details
Table 74. CIDIC Company Limited Business Overview
Table 75. CIDIC Company Limited Monkeypox Treatment Product
Table 76. CIDIC Company Limited Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 77. CIDIC Company Limited Recent Developments
Table 78. Emcure Pharmaceuticals Company Details
Table 79. Emcure Pharmaceuticals Business Overview
Table 80. Emcure Pharmaceuticals Monkeypox Treatment Product
Table 81. Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 82. Emcure Pharmaceuticals Recent Developments
Table 83. Emergent Company Details
Table 84. Emergent Business Overview
Table 85. Emergent Monkeypox Treatment Product
Table 86. Emergent Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 87. Emergent Recent Developments
Table 88. Gilead Sciences Inc. Company Details
Table 89. Gilead Sciences Inc. Business Overview
Table 90. Gilead Sciences Inc. Monkeypox Treatment Product
Table 91. Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 92. Gilead Sciences Inc. Recent Developments
Table 93. Hetero Drugs Limited Company Details
Table 94. Hetero Drugs Limited Business Overview
Table 95. Hetero Drugs Limited Monkeypox Treatment Product
Table 96. Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 97. Hetero Drugs Limited Recent Developments
Table 98. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
Table 99. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
Table 100. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product
Table 101. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 102. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Developments
Table 103. Mylan N.V. Company Details
Table 104. Mylan N.V. Business Overview
Table 105. Mylan N.V. Monkeypox Treatment Product
Table 106. Mylan N.V. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 107. Mylan N.V. Recent Developments
Table 108. Olon S.p.A. Company Details
Table 109. Olon S.p.A. Business Overview
Table 110. Olon S.p.A. Monkeypox Treatment Product
Table 111. Olon S.p.A. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 112. Olon S.p.A. Recent Developments
Table 113. Piramal Pharma Solutions Company Details
Table 114. Piramal Pharma Solutions Business Overview
Table 115. Piramal Pharma Solutions Monkeypox Treatment Product
Table 116. Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 117. Piramal Pharma Solutions Recent Developments
Table 118. SIGA Technologies Inc. Company Details
Table 119. SIGA Technologies Inc. Business Overview
Table 120. SIGA Technologies Inc. Monkeypox Treatment Product
Table 121. SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 122. SIGA Technologies Inc. Recent Developments
Table 123. Sonofi SA Company Details
Table 124. Sonofi SA Business Overview
Table 125. Sonofi SA Monkeypox Treatment Product
Table 126. Sonofi SA Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 127. Sonofi SA Recent Developments
Table 128. Teva Pharmaceutical Industries Limited Company Details
Table 129. Teva Pharmaceutical Industries Limited Business Overview
Table 130. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product
Table 131. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2018-2023) & (US$ Million)
Table 132. Teva Pharmaceutical Industries Limited Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monkeypox Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Monkeypox Treatment Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Injectable Features
Figure 5. Global Monkeypox Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Monkeypox Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Monkeypox Treatment Report Years Considered
Figure 11. Global Monkeypox Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Monkeypox Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Monkeypox Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Monkeypox Treatment Market Share by Players in 2022
Figure 15. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Monkeypox Treatment Revenue in 2022
Figure 17. North America Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Monkeypox Treatment Market Share by Type (2018-2033)
Figure 19. North America Monkeypox Treatment Market Share by Application (2018-2033)
Figure 20. North America Monkeypox Treatment Market Share by Country (2018-2033)
Figure 21. United States Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Monkeypox Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Monkeypox Treatment Market Share by Type (2018-2033)
Figure 25. Europe Monkeypox Treatment Market Share by Application (2018-2033)
Figure 26. Europe Monkeypox Treatment Market Share by Country (2018-2033)
Figure 27. Germany Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Monkeypox Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Monkeypox Treatment Market Share by Type (2018-2033)
Figure 35. China Monkeypox Treatment Market Share by Application (2018-2033)
Figure 36. Asia Monkeypox Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Monkeypox Treatment Market Share by Type (2018-2033)
Figure 38. Asia Monkeypox Treatment Market Share by Application (2018-2033)
Figure 39. Asia Monkeypox Treatment Market Share by Region (2018-2033)
Figure 40. Japan Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Monkeypox Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Monkeypox Treatment Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Monkeypox Treatment Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Monkeypox Treatment Market Share by Country (2018-2033)
Figure 50. Brazil Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Monkeypox Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Bavarian Nordic Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 57. Chimerix, Inc. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 58. CIDIC Company Limited Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 59. Emcure Pharmaceuticals Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 60. Emergent Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 61. Gilead Sciences Inc. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 62. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 63. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 64. Mylan N.V. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 65. Olon S.p.A. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 66. Piramal Pharma Solutions Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 67. SIGA Technologies Inc. Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 68. Sonofi SA Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 69. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Treatment Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries